Matrix metalloproteases (MMPs) are a family of neutral proteases responsible for degrading components of the extracellular matrix. These enzymes have similar structural and biochemical properties, including their dependency on zinc ions for catalytic activity. There are at least six different sub-families, grouped on the basis of their substrate specificity: collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs and other MMPs. 1 The collagenase sub-family of MMPs has three members: MMP-1 (collagenase-1 or interstitial collagenase), MMP-8 (collagenase-2 or neutrophilcollagenase) and MMP-13 (collagenase-3). MMP-13 expression has been established in squamous cell carcinomas, osteoarthritis, rheumatoid arthritis, tumor metastasis into bone and destructive periodontal disease. 2 In addition, MMP-13 expression has been positively correlated with periodontal disease progression in humans. 3 One of the main virulence factors of Gram-negative bacterial bacteria is endotoxin, a lipopolysaccharide (LPS) component of the bacterial cell wall surface, which is able to induce an immune/inflammatory host response. 4, 5 Previous studies having shown that LPS is the immunodominant antigen expressed in Actinobacillus actinomycetemcomitans. 6 Recent studies have shown that A. actinomycetemcomitans can induce inflammatory bone Matrix metalloprotease-13 (MMP-13) is induced by pro-inflammatory cytokines and increased expression is associated with a number of pathological conditions such as tumor metastasis, osteoarthritis, rheumatoid arthritis and periodontal diseases. MMP-13 gene regulation and the signal transduction pathways activated in response to bacterial LPS are largely unknown. In these studies, the role of the mitogen-activated protein kinase (MAPK) pathways in the regulation of MMP-13 induced by lipopolysaccharide was investigated. Lipopolysaccharide from Escherichia coli and Actinobacillus actinomycetemcomitans significantly (P < 0.05) increased MMP-13 steady-state mRNA (average of 27% and 46% increase, respectively) in murine periodontal ligament fibroblasts. MMP-13 mRNA induction was significantly reduced by inhibition of p38 MAP kinase. Immunoblot analysis indicated that p38 signaling was required for LPS-induced MMP-13 expression. Lipopolysaccharide induced proximal promoter reporter (-660/+32 mMMP-13) gene activity required p38 signaling. Collectively, these results indicate that lipopolysaccharide-induced murine MMP-13 is regulated by p38 signaling through a transcriptional mechanism.
INTRODUCTION loss in mice. 7, 8 A. actinomycetemcomitans has been linked to aggressive periodontitis (AP) -it is found in AP lesions, 9 AP patients exhibit elevated serum antibodies to A. actinomycetemcomitans, 10, 11 and reduction of A. actinomycetemcomitans improves the clinical response of AP patients. 12 Recent interest in innate immunity signaling through Toll-like receptors (TLRs) with A. actinomycetemcomitans LPS indicates that, in gingival fibroblasts, LPS can stimulate IL-6 and IL-8 through a MyD88/TLR-4 mechanism. 13 Other studies in periodontally relevant cells support LPS-induced cytokine and chemokine production. [14] [15] [16] Due to the anatomical location within the periodontium, periodontal ligament fibroblasts can actively participate in both anabolic and catabolic processes of bone remodeling, as observed in orthodontic tooth movement. 17, 18 Indeed, periodontal ligament fibroblasts express IL-6 and IL-8 in response to LPS stimulation, 14, 19 indicating a potential to participate in inflammation and tissue remodeling. Moreover, human periodontal ligament fibroblasts express MMP-13 upon stimulation with IL-1α 20 and also with TNF-α. 21 We have shown that IL-1β and TNF-α also induce MMP-13 expression in mouse periodontal ligament cells through a complex mechanism involving negative regulation by p38 MAPK; 22 however, no studies have addressed LPS-induced MMP-13 expression and MAPK signaling pathways required for expression.
MATERIALS AND METHODS

Cells and materials
Murine periodontal ligament cells were obtained from M. Sommerman (University of Washington) and cultured in DMEM supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin and 10% heat-inactivated fetal bovine serum and maintained in a humidified atmosphere at 37°C and 5% CO 2 as previously described. 22, 23 LPS from Escherichia coli (serotype O127:B8) was purchased from Sigma and A. actinomycetemcomitans LPS was extracted from A. actinomycetemcomitans strain Y4 (serotype B) by the hot phenol-water method as described. 6 Both E. coli and A. actinomycetemcomitans LPS were diluted in serum-free defined culture medium (Opti-MEM, Invitrogen) at 1 mg/ml and used at a final concentration in tissue culture of 1 µg/ml.
The biochemical inhibitors against p38 (SB203580), JNK (SP600125) and ERK (PD98059) were from Calbiochem. Rabbit polyclonal antibodies against phosphorylated and non-phosphorylated forms of p38 MAP kinases were from Cell Signaling, as well as the secondary HRP-conjugated antibodies. Monoclonal antibodies against mouse TLR-2/4, MMP-13 and GAPDH were from Abcam, Calbiochem and Chemicon, respectively. Anti-mouse-and rabbit Alexa488-conjugated secondary antibodies were purchased from Invitrogen/Molecular Probes.
Fluorescent microscopy
Murine periodontal ligament fibroblasts were cultured on chamber slides (Corning Costar) for 24 h. Cells were methanol fixed and permeabilized with 0.1% Triton X100. Following blocking with 1% bovine serum albumin (BSA), primary antibodies against TLR-2 or TLR-4 were incubated at 1:50 dilution. Labeled cells were detected by Alexa488-conjugated secondary antibodies (Molecular Probes) and slides were mounted with SlowFade Antifade Kit (Invitrogen/ Molecular Probes). Images were obtained using a Nikon E800 light microscope with Nomarski Differential Interference Contrast optics (DIC) to enhance contrast of samples fitted with appropriate filter sets. Images were acquired using a Nikon CCD camera and Image Pro-Plus v.5.1 software.
Semi-quantitative RT-PCR and siRNA
Total RNA was harvested using Trizol reagent according to the manufacturer's instructions. After further purification and DNase treatment with the RNeasy kit (Qiagen), cDNA was synthesized by reverse transcription (RT) according to the manufacturer's protocol (Applied Biosystems). A 2-µl aliquot of the RT reaction product was used in PCR reactions. Primer sequences for Tolllike receptors (TLRs) used in the present study were: TLR-2 (accession# NM01 1905) sense 5′-TCT-GGGCAGTCTTGACATTT-3′; antisense 5′-AGAGTC-AGGTGATGGATGTCG-3′ spanning exon2/intron2; TLR4 (accession# NM02 1297) sense 5′-AGCAGAG-GAGAAGCATCTATGATGC-3′; antisense 5′-GGT-TTAGGCCCCAGAGTTTTGTTCTCC-3′ spanning intron 1. These primers yielded products of 321 bp and 540 bp after 30 and 28 cycles. PCR conditions were optimized for cycle number. The primer pair used for MMP-13 (accession# NM00867) were: sense 5′-GGTCCCAAC-GAAACTTACA-3′; antisense 5′-CCTTGACGTCAT-CATCAGGAGC-3′ spanning exon 2/intron boundary, while the primer pair for GAPDH (accession# BC083065) were sense 5′-CACCATGGAGAGGCCGGGG-3′, antisense 5′-GACGGACACATTGGGGGTAG-3′ spanning the first intron of the gene. PCR reactions yielded products of 445 bp and 418 bp for MMP-13 and GAPDH, respectively. Taq DNA polymerase and other PCR reagents were purchased from Invitrogen. Both cycle number and PCR conditions were optimized to ensure cycle numbers were within the linear range of amplification.
PCR products were resolved with agarose gels stained with ethidium bromide. Densitometric measurements were obtained with a digital documentation system (Gel Doc XR, Bio-Rad). MMP-13 mRNA quantities in each sample were subsequently normalized to the quantity of GAPDH mRNA and expressed as fold change over unstimulated control.
Silencing RNA for p38 MAP kinase was purchased as a kit (Cell Signaling) and used according to manufacturer's instructions. Briefly, 1.5 x 10 4 cells were plated in 12-well plates. After 24-h culture, cells were transiently transfected with 20 nM of pooled p38 MAPK siRNA and 2 µl of transfection reagent. Fresh culture medium containing 0.3% FBS was added on the next day, and cells were stimulated with the LPS. After the indicated treatment periods, total RNA was harvested and RT-PCR was performed. The negative control in this kit was fluorescence detection of a control siRNA. Initial experiments with negative control were performed to optimize siRNA transfection conditions.
Western blot analysis
Expression at the protein level was evaluated from cell culture supernatants harvested 24 h after treatment. After a brief centrifugation step to clear cell debris from supernatants, conditioned media were concentrated using Centricon Plus filters (Millipore) with nominal molecular mass cut-off of 30 kDa and centrifugation at 3000 g for 90 min at 4°C. Total protein (40 µg) was loaded on SDS-polyacrylamide gels and electrotransferred to nitrocellulose membranes, blocked, and then incubated overnight at 4°C with primary antibodies. The presence of the primary antibodies was detected on radiographic film by using HRP-conjugated secondary antibody and a chemiluminescence system (Lumi-Glo, Cell Signaling). Digital images of chemiluminescence activity were obtained on a digital gel documentation system (Gel Doc XR, Bio-Rad).
Stable transfections
The plasmid pGL3-basic containing the -660/+32 fragment of mouse MMP-13 promoter relative to the transcriptional start site was obtained from Dr Jeffery M. Davidson (Vanderbilt University). 24 Through co-transfection with pcDNA 3.1-neo plasmid, stable ligament fibroblast cell lines were established with media containing 800 µg/ml of neomycin (G418, Invitrogen). The resultant polyclonal population was used for reporter assays and firefly luciferase expression was evaluated on whole cell lysates using the dual-luciferase assay kit (Promega) with an L-Max II luminometer (Molecular Devices). Results were normalized to total protein concentration in the cell lysates, as determined by the Bradford method (Bio-Rad).
Statistical analysis
Pair-wise comparisons between experimental groups were performed using the t-test with Welch's correction for unequal variances. Significance level was set to 5% and all calculations were performed using Prism 4 software (Graph Pad, Inc.).
RESULTS
Mouse ligament fibroblasts express TLR-4 mRNA and protein that is not regulated by E. coli and A. actinomycetemcomitans LPS
To understand the molecular nature of LPS-induced gene expression in murine periodontal ligament fibroblasts, TLR-4 expression was determined to indicate these cells have the capacity to respond to bacterialderived LPS. Ligament fibroblasts were stimulated with E. coli or A. actinomycetemcomitans LPS in the presence or absence of the p38 MAP kinase inhibitor SB203580 for 18 h. E. coli LPS was chosen since this LPS represents one the classical TLR-4 agonists commercially available. RT-PCR analysis indicated that TLR4 mRNA is expressed in ligament fibroblasts ( Fig.  1A) , indicating that these cells have the capacity to signal through receptors in response to LPS stimulation. Moreover, additional RT-PCR analysis indicated TLR-4 mRNA was not regulated by LPS and p38 MAP kinase, suggesting that the effects on gene expression observed with the both LPS and with the p38 inhibitor could not be attributed to regulation of receptor altering the signaling capacity in these cells.
Epifluorescent microscopy was used to show surface and intracellular staining upon LPS stimulation with E. coli or A. actinomycetemcomitans LPS (Fig. 1B) . Results indicate that TLR-4 receptors are expressed on the cell surface and intracellularly. In addition, strong perinuclear intracellular staining was observed in TLR-4 stained cells.
LPS from E. coli and A. actinomycetemcomitans induces MMP-13 mRNA in ligament fibroblasts through p38 MAP kinase pathways E. coli and A. actinomycetemcomitans LPS were used to stimulate murine ligament fibroblasts cells for 18 h as described above. Data from previous studies indicated that MMP-13 expression was increased at 8 h and 18 h in p38 MAPK regulates MMP-13 expression 87 response LPS and IL-1β. 22 Both E. coli and A. actinomycetemcomitans LPS induced a significant (P < 0.05) increase in MMP-13 mRNA expression of about 1.5-fold when normalized to GAPDH ( Fig. 2A,B) . Interestingly, both E. coli and A. actinomycetemcomitans LPS use the same MAP kinase signal pathways for MMP-13 activation. Inhibition of p38 MAP kinase resulted in significant decrease on E. coli and A. actinomycetemcomitans LPSinduced MMP-13 mRNA, whereas inhibition of JNK and ERK pathways did not significantly affect LPS-induced MMP-13 expression (Fig. 2B) . The role of p38 MAP kinase on LPS-induced MMP-13 mRNA expression was further confirmed by inhibition of p38 gene expression by siRNA (Fig. 2C ). Addition of commercially available siRNA reduced p38 in periodontal ligament fibroblasts 48 h post-transfection by approximately 80%. Global effects on protein levels were not observed since GAPDH protein levels were not reduced. The transfection reagent alone also did not reduce protein synthesis either. Following p38 knock-down, neither E. coli nor A. actinomycetemcomitans LPS was able to induce MMP-13 mRNA expression (Fig.  2D) . The targeted specific gene knockdown of p38 MAP kinase resulted in specific reduction of LPS-induced MMP-13 expression by RT-PCR. Negative control for RT-PCR (H 2 O) indicates entire PCR reaction mixture except RT product (cDNA template).
MMP-13 protein secretion is inhibited primarily by blocking p38 MAP kinase
To determine if protein expression and MMP-13 function were affected by p38, immunoblot analysis with concentrated cell supernatants was performed ( Fig. 3) . Conditioned media used in these experiments were harvested 24 h following the treatments described for steady-state mRNA experiments. In agreement with mRNA expression levels of MMP-13, inhibition of MMP-13 protein was achieved by inhibiting p38 MAP kinase. However, inhibition of ERK MAP kinases had the opposite effect; increasing total MMP-13 protein after stimulation with both LPS (data not shown).
Transcriptional mechanisms are involved in LPSinduced MMP-13 expression
To gain insight into the nature of p38 regulation of MMP-13 expression in periodontal ligament fibroblasts, stable reporter cells were generated harboring 660 bp of the proximal mouse MMP-13 gene promoter. This promoter contains the majority of transcription factor consensus sequences previously identified as essential for MMP-13 gene expression. 25 Reporter constructs containing more proximal elements relative to the transcription start site failed to reflect endogenous MMP-13 mRNA regulation (data not shown). Luciferase reporter gene experiments indicated that promoter activity was increased upon stimulation with LPS from both E. coli and A. actinomycetemcomitans (Fig. 4 ). However, in the presence of a p38 MAP kinase inhibitor, LPS-induced reporter gene expression was significantly decreased (E. coli LPS P = 0.013 and A. actinomycetemcomitans Y4 LPS P = 0.043), whereas inhibition of JNK and ERK resulted in an increase on promoter activity in unstimulated cells (data not shown). 
DISCUSSION
The role of bacteria in the initiation and progress of periodontal disease is undisputed, and LPS is one of the main pathogen-associated molecular patterns (PAMPs) that can stimulate the expression and production of proinflammatory cytokines that will ultimately lead to the degradation of soft and hard tissue. However, the role of LPS in of MMP-13 expression in ligament cells has not been addressed and the signaling pathways involved were largely unknown.
In the present study, results indicate that LPS from E. coli and A. actinomycetemcomitans can induce a significant increase in MMP-13 expression in periodontal ligament fibroblasts. These in vitro results contrast with others, 26 that did not include MMP-13 as one of the five gene transcripts consistently increased in human periodontal ligament fibroblasts stimulated with LPS from Porphyromonas gingivalis. Since we used murine ligament cell models, this discrepancy may be due to species-specificity issues, or to differences in biological activity of LPS obtained from different bacterial species. However, studies with human tissue samples have shown that MMP-13 is one of several matrix metalloproteinases increased in periodontal diseased tissues. 3 Toll-like receptors (TLRs) are considered to be essential for LPS-induced signaling. Numerous reports demonstrating that gingival and periodontal ligament fibroblasts respond to LPS stimulation provide evidence to indicate that these cells are equipped with TLRs. 14, 19, 27 We observed that the murine ligament cell line used expressed mRNA and protein for TLR-4. Moreover, this expression was not regulated by LPS stimulation. Fluorescent microscopy indicated that TLR-4 was expressed on periodontal ligament fibroblasts under all experimental conditions evaluated. Recently, our laboratory has reported that p38 MAP kinase negatively regulates MMP-13 expression when induced by IL-1β and TNF-α in ligament fibroblasts. 22 In contrast, results herein describe LPS stimulated MMP-13 requires p38 signaling in the same cells though a transcriptional mechanism utilizing the proximal promoter. These data were obtained with biochemical inhibitors and substantiated through specific p38 gene knock-down studies. These reports highlight the complexity of MMP-13 regulation indicating that expression of this gene is modulated in stimulus-specific manner and MAP kinase pathways have a predominant and reciprocal role in regulation. In contrast to our findings, ERK was shown to regulate LPS-induced MMP-9 expression positively by a mechanism that also involves the PKC pathway, while p38 MAP kinase was a negative regulator of LPS-induced MMP-9 expression. 28 Recently, differential regulation of LPS-induced MMP-1 and MMP-9 expression by p38 MAP kinase was also demonstrated in monocytes. 29 In these cells, inhibition of p38 decreased LPS-induced MMP-1 expression, but resulted in increased ERK activation and MMP-9 expression.
To date, no other reports on the signaling pathways involved in periodontal disease associated LPS-induced MMP-13 expression, exist; however, in contrast to our findings, ERK signaling was required for LPS-induced MMP-9 expression in astrocytes, while p38 MAP kinase was a negative regulator of LPS-induced MMP-9 expression in the same study. 28 Recently, differential regulation of LPS-induced MMP-1 and MMP-9 expression by p38 MAP kinase was also demonstrated in monocytes. 29 In these cells, inhibition of p38 decreased LPSinduced MMP-1 expression, but resulted in increased ERK activation and MMP-9 expression. On the other hand, blocking ERK decreased expression of both MMP-1 and MMP-9. LPS signals used the same pathways in human monocytes and in mouse ligament fibroblasts cells, involving the same MAP kinase pathways, p38 and ERK. However, inhibition of ERK did not affect phosphorylation of p38 MAP kinase induced by LPS in the murine ligament fibroblast cells or macrophages. 30 There is evidence that the IKK/NF-κB pathway is also activated by LPS in various cell types, including macrophages, osteoclasts and endothelial cells. 31, 32 Even though LPS-induced MMP-2 expression by endothelial cells 32 as well as LPS-induced MMP-9 expression in monocytes 29 involves activation of IKK/NF-κB pathway, there is no information on the relevance of this pathway to MMP-13 gene expression induced by LPS. Considering that our findings suggest that transcriptional mechanisms can be accounted for LPS-induced MMP-13, and since a number of binding motifs for different transcription factors can be found on the MMP-13 promoter (including AP-1, PEA3, SP1, Runx2, p53, NF-κB, OSE-2, C/EBP, CREB and Elk-1), it is interesting to evaluate the transcription factors activated in a p38-and ERK-dependent manner. Also, the role of NF-κB as a possible downstream substrate of p38 MAPK, as well as the participation of Nod proteins in LPS signal transduction in these cells, will be addressed in future studies. MMP-13 gene regulation is complex, and may involve not only multiple signaling pathways, but also transcriptional 33 and post-transcriptional mechanisms, 34 depending on both cell type and external stimuli.
LPS also induces the production of a number of proinflammatory cytokines that can feedback in an autocrine manner to affect MMP-13 gene expression, such as PGE 2 , TNF-α, IL-6, IL-8, and IL-1. 19, 20, 31 However, this indirect regulation of MMP genes by other endogenous pro-inflammatory cytokines induced by the same extracellular stimuli may be signaling pathway-and MMP isotype-specific. This is demonstrated in MMP-1 expression by LPS-stimulated monocytes, which was regulated by p38 MAPK in a PGE 2dependent pathway, whereas regulation by ERK pathway occurred through transcriptional mechanisms independently of PGE 2 . On the other hand, LPS-induced MMP-9 expression in monocytes was regulated mainly by ERK through PGE 2 -independent mechanisms. 29 Woo et al. 30 have shown that LPS-induced MMP-9 activity in murine macrophages was completely abrogated by inhibiting p38, whereas it was discretely inhibited by blocking ERK MAP kinase.
CONCLUSIONS
MMP-13 gene regulation is complex, involving not only multiple signaling pathways, but also transcriptional and post-transcriptional mechanisms, depending on both cell type and external stimuli. These present studies high-light this complexity and support the role of p38 signaling in LPS-induced MMP-13 expression. Further studies on the transcription factors involved may yield new information regarding the molecular nature of LPS-induced MMP-13 gene regulation, providing insight into new therapeutic approaches not only to periodontal disease management but other chronic inflammatory bone diseases.
